NEWTON, Mass.--(BUSINESS WIRE)--Matritech (Amex: MZT), a leading developer and marketer of protein-based diagnostic products for the early detection of cancer, today reported financial results for the first quarter ended March 31, 2007. The Company also reaffirmed its full year guidance of $14.5 to $15.5 million in total revenues.
